VA

VR Adviser Portfolio holdings

AUM $1.33B
1-Year Est. Return 6.92%
This Quarter Est. Return
1 Year Est. Return
+6.92%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$511M
AUM Growth
+$93.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
29
New
Increased
Reduced
Closed

Top Buys

1
+$28.1M
2
+$18M
3
+$17.8M
4
CLDX icon
Celldex Therapeutics
CLDX
+$11.9M
5
MTCR
Metacrine, Inc. Common Stock
MTCR
+$11.7M

Top Sells

1
+$24.5M
2
+$17.4M
3
+$11.4M
4
AVDL
Avadel Pharmaceuticals
AVDL
+$8.55M
5
ADAP
Adaptimmune Therapeutics
ADAP
+$7.83M

Sector Composition

1 Healthcare 72.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$102M 20.03%
7,204,577
+414,577
2
$81.4M 15.92%
4,016,873
3
$59.4M 11.62%
4,500,000
4
$28.1M 5.5%
+1,521,623
5
$26.8M 5.23%
3,877,895
6
$25.9M 5.07%
672,306
7
$25.1M 4.92%
668,440
8
$18M 3.53%
+1,271,985
9
$17.8M 3.47%
+400,000
10
$17.6M 3.45%
575,000
11
$15.3M 3%
1,192,883
-238,752
12
$11.9M 2.32%
+800,000
13
$11.7M 2.28%
+1,143,673
14
$11.3M 2.21%
+300,000
15
$10.2M 1.99%
+1,088,818
16
$9.23M 1.81%
625,710
17
$5.6M 1.1%
+500,000
18
$5.18M 1.01%
+500,000
19
$2.6M 0.51%
+107,982
20
$467K 0.09%
+51,653
21
$383K 0.07%
+92,453
22
– –
-781,940
23
– –
-1,057,827
24
– –
-291,140
25
– –
-2,765,000
1
2